IL113595A - Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain - Google Patents

Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain

Info

Publication number
IL113595A
IL113595A IL11359595A IL11359595A IL113595A IL 113595 A IL113595 A IL 113595A IL 11359595 A IL11359595 A IL 11359595A IL 11359595 A IL11359595 A IL 11359595A IL 113595 A IL113595 A IL 113595A
Authority
IL
Israel
Prior art keywords
protein
haemophilus influenzae
nontypable haemophilus
antigen
outer membrane
Prior art date
Application number
IL11359595A
Other languages
English (en)
Other versions
IL113595A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL113595A0 publication Critical patent/IL113595A0/xx
Publication of IL113595A publication Critical patent/IL113595A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL11359595A 1994-05-05 1995-05-03 Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain IL113595A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/210,394 US5770213A (en) 1994-05-05 1994-05-05 Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection

Publications (2)

Publication Number Publication Date
IL113595A0 IL113595A0 (en) 1995-08-31
IL113595A true IL113595A (en) 2001-05-20

Family

ID=22782738

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11359595A IL113595A (en) 1994-05-05 1995-05-03 Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain

Country Status (14)

Country Link
US (2) US5770213A (de)
EP (1) EP0680765B1 (de)
JP (2) JP4236215B2 (de)
KR (1) KR100366482B1 (de)
AT (1) ATE356633T1 (de)
AU (1) AU704882B2 (de)
CA (1) CA2148563C (de)
DE (1) DE69535422T2 (de)
DK (1) DK0680765T3 (de)
ES (1) ES2282992T3 (de)
FI (1) FI120149B (de)
IL (1) IL113595A (de)
NO (1) NO951750L (de)
PT (1) PT680765E (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002089839A1 (en) * 2001-05-03 2002-11-14 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella catarrhalis
US20040126381A1 (en) * 1996-04-23 2004-07-01 Xin-Xing Gu Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
US6974581B1 (en) * 1998-12-15 2005-12-13 Aventis Pasteur Limited Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
GB9904183D0 (en) * 1999-02-24 1999-04-14 Smithkline Beecham Biolog Novel compounds
US7101989B1 (en) 1999-07-09 2006-09-05 University Of North Carolina At Chapel Hill DsrA protein and polynucleotides encoding the same
GB0025486D0 (en) * 2000-10-17 2000-11-29 Smithkline Beecham Biolog Novel compounds
AU2003250673A1 (en) * 2002-07-24 2004-02-09 Id Biomedical Corporation Polypeptides of nontypeable haemophilus influenzae
IL308456A (en) 2005-04-08 2024-01-01 Wyeth Llc A multivalent pneumomuroral protein-polysaccharide conjugate preparation
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
CN102159225B (zh) 2008-09-17 2013-11-13 亨特免疫有限公司 不可分型流感嗜血杆菌疫苗和它们的用途
KR102409709B1 (ko) 2021-11-30 2022-06-16 박정민 케이블 접속장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300632A (en) * 1986-11-18 1994-04-05 Research Foundation Of State University Of New York Method for purifying an outer membrane protein of Haemophilus influenzae
US5098997A (en) * 1987-12-11 1992-03-24 Praxis Biologics, Inc. Vaccines for Haemophilus influenzae
US5098987A (en) * 1989-07-13 1992-03-24 The United States Of America As Represented By The Secretary Of The Air Force Crosslinkable rigid-rod benzobisazole polymer
JP3429313B2 (ja) 1993-05-18 2003-07-22 オハイオ・ステイト・リサーチ・ファウンデーション 中耳炎ワクチン

Also Published As

Publication number Publication date
JP4236215B2 (ja) 2009-03-11
ES2282992T3 (es) 2007-10-16
KR100366482B1 (ko) 2003-08-02
EP0680765A1 (de) 1995-11-08
CA2148563A1 (en) 1995-11-06
JP2009051859A (ja) 2009-03-12
CA2148563C (en) 2008-10-07
PT680765E (pt) 2007-05-31
JPH08337598A (ja) 1996-12-24
DE69535422D1 (de) 2007-04-26
USRE37741E1 (en) 2002-06-11
AU1781495A (en) 1995-11-16
ATE356633T1 (de) 2007-04-15
DE69535422T2 (de) 2007-12-13
AU704882B2 (en) 1999-05-06
KR950031108A (ko) 1995-12-18
DK0680765T3 (da) 2007-07-02
FI120149B (fi) 2009-07-15
FI952144L (fi) 1995-11-06
US5770213A (en) 1998-06-23
IL113595A0 (en) 1995-08-31
EP0680765B1 (de) 2007-03-14
FI952144A0 (fi) 1995-05-04
NO951750L (no) 1995-11-06
NO951750D0 (no) 1995-05-04

Similar Documents

Publication Publication Date Title
EP0462210B1 (de) Impfstoffe gegen hämophilus influenzae
US8992936B2 (en) Altered OspA of Borrelia burgdorferi
JP2009051859A (ja) 非型性のヘモフィルスインフルエンザ（Ｈａｅｍｏｐｈｉｌｕｓｉｎｆｌｕｅｎｚａｅ）株用のワクチンとしての精製非型性ヘモフイルスインフルエンザＰ５蛋白質
JP2015212284A (ja) ポルフィロモナス・ジンジバリス感染の予防、治療及び診断
JP4358909B2 (ja) 歯周炎の診断および治療用のポルフィロモナス・ジンジバリス抗原
KR960016208B1 (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법.
JP2003520765A (ja) ポルフィロモナス・ジンジヴァリスによる歯周炎の治療及び予防のための保護エピトープを含有する合成ペプチド
AU651030B2 (en) Vaccines and diagnostic assays for haemophilus influenzae
RU2186582C2 (ru) Способ выделения и очистки белка внешней мембраны moraxella catarrhalis, штамм м.catarrhalis для получения белка cd, изолированный и очищенный неденатурированный белок cd внешней мембраны м.catarrhalis и иммуногенная композиция, содержащая белок cd внешней мембраны м.сatarrhalis
CA2719041C (en) A method for identifying polypeptides which comprise a cross-reactive antigenic determinant
AU723159B2 (en) High molecular weight surface proteins of non-typeable haemophilus
WO2004041182A2 (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
KR101991577B1 (ko) 다수의 에피토프로 구성된 재조합 항원 단백질 및 이의 제조방법
RU2196176C2 (ru) АНАЛОГ HIN47 Haemophilus С РЕДУЦИРОВАННОЙ ПРОТЕАЗНОЙ АКТИВНОСТЬЮ
Choi et al. Study on the Antigens for Cell Free Vaccine and Retrospective Diagnosis of Anthrax: Production of Protective Antigen of Bacillus anthracis: Production of Protective Antigen of Bacillus anthracis
NZ272660A (en) Pasteurella multocida antigens, antibodies, their production and use
Choi et al. Study on the Antigens for Cell Free Vaccine and Retrospective Diagnosis of Anthrax: Production of Protective Antigen of
Green et al. Overview: Bacterial Lipoproteins as Vaccines Candidates and Patent Considerations
HK1111735A (en) Altered ospa of borrelia burgdorferi

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees